# Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

> **NCT02559934** · PHASE1 · COMPLETED · sponsor: **G&E Herbal Biotechnology Co., LTD** · enrollment: 12 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** SR-T100 Gel

## Key facts

- **NCT ID:** NCT02559934
- **Lead sponsor:** G&E Herbal Biotechnology Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2019-01
- **Final completion:** 2019-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02559934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02559934, "Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02559934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*